Organization
Dynavax Technologies Corporation
3 clinical trials
Clinical trial
Phase 2, Randomized, Active-Controlled, Observer-Blinded, Multicenter Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of AgeStatus: Active (not recruiting), Estimated PCD: 2023-10-03
Clinical trial
HEPLISAV-B Pregnancy Registry: An Observational Study on the Safety of HEPLISAV-B Exposure in Pregnant Women and Their OffspringStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
A Phase 1 Randomized, Subject-Blinded, Active-Controlled, Dose Escalation, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers Between the Ages of 50 and 69 YearsStatus: Completed, Estimated PCD: 2022-10-20